Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Yondelis in Men with Advanced Prostate Carcinoma
2006-002276-17Phase 2Completed
- Sponsor
- PharmaMar
- Start
- Jun 2006
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of trabectedin in prostate cancer (PCa), sponsored by PharmaMar. Primary endpoints: PSA response, Duration of response and 1 more. Started Jun 2006; status: completed.
02
Drugs
trabectedin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2006-002276-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002276-17.